Sanofi: FDA grants fast track designation to chlamydia vaccine candidate

The US Food and Drug Association (FDA) has granted fast track designation to Sanofi's mRNA vaccine candidate for the prevention of chlamydia infection. The chlamydia vaccine candidate has been designed to protect against primary genital tract infection and reinfection caused by the bacterium Chlamydia trachomatis. Sanofi is an international pharma and healthcare company, providing vaccination [...] The post FDA grants fast track designation to chlamydia vaccine candidate appeared first on Pharmafile.